References
- Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(14):1690–1702.
- Tang Y, Liu H, Li H, et al. Hypermethylation of the HLA-G promoter is associated with preeclampsia. Mol Hum Reprod. 2015;21(9):736–744.
- Le Bouteiller P, Pizzato N, Barakonyi A, et al. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol. 2003;59(2):219–234.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
- Correa PJ, Palmeiro Y, Soto MJ, et al. Etiopathogenesis, prediction, and prevention of preeclampsia. Hypertens Pregnancy. 2016;35(3):280–294.
- McMaster MT, Librach CL, Zhou Y, et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol. 1995;154(8):3771–3778.
- Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990;248(4952):220–223.
- Rizzo R, Andersen AS, Lassen MR, et al. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy. Am J Reprod Immunol. 2009;62(5):320–338.
- Kapasi K, Albert SE, Yie S, et al. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology. 2000;101(2):191–200.
- Quach K, Grover SA, Kenigsberg S, et al. A combination of single nucleotide polymorphisms in the 3′untranslated region of HLA-G is associated with preeclampsia. Hum Immunol. 2014;75(12):1163–1170.
- Hylenius S, Andersen AM, Melbye M, et al. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod. 2004;10(4):237–246.
- Iversen AC, Nguyen OT, Tømmerdal LF, et al. The HLA-G 14bp gene polymorphism and decidual HLA-G 14bp gene expression in pre-eclamptic and normal pregnancies. J Reprod Immunol. 2008;78(2):158–165.
- Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497–506.
- Lowe SA, Bowyer L, Lust K, et al. SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol. 2015;55(5):e1–29.
- National Guideline A. National institute for health and care excellence: Clinical guidelines. Hypertension in pregnancy: diagnosis and management. London: National Institute for Health and Care Excellence (UK) Copyright© NICE 2019; 2019.
- Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia – current management and future approach. Curr Pharm Biotechnol. 2018;19(10):786–796.
- Durmanova V, Drobny J, Shawkatova I, et al. Analysis of HLA-G gene polymorphisms in slovak women with pre-eclampsia. Bratisl Lek Listy. 2017;118(9):517–522.
- Hertig A, Liere P. New markers in preeclampsia. Clin Chim Acta. 2010;411(21–22):1591–1595.
- González A, Rebmann V, LeMaoult J, et al. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 2012;49(3):63–84.
- Emmer PM, Joosten I, Schut MH, et al. Shift in expression of HLA-G mRNA spliceforms in pregnancies complicated by preeclampsia. J Soc Gynecol Investig. 2004;11(4):220–226.
- Bermingham J, Jenkins D, McCarthy T, et al. Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia. Biochem Soc Trans. 2000;28(2):215–219.
- Kim JJ, Hong SJ, Hong YM, et al. Genetic variants in the HLA-G region are associated with kawasaki disease. Hum Immunol. 2008;69(12):867–871.
- Ferreira LC, Lopes TPB, Guimarães TB, et al. The maternal 14 bp Ins/Del polymorphism in HLA-G is not associated with preeclampsia risk. Int J Immunogenet. 2017;44(6):350–355.